Induction of suppressors of cytokine signaling by the trichothecene deoxynivalenol in the mouse

Toxicological Sciences

Volumn 111, Issue 2, 2009, Pages 277-287

  Amuzie, Chidozie J ^a   Shinozuka, Junko ^b,c   Pestka, James J ^a,b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Michigan State University   (United States)

^c MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Cytokines; Deoxynivalenol; SOCS3

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA; PROTEIN SH2; SOMATOMEDIN; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA; VOMITOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE INDUCTION; GENE LOCATION; LIVER; MUSCLE; NONHUMAN; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPLEEN; TOXICOKINETICS; UPREGULATION;

ANIMALS; FEMALE; IMMUNOCHEMISTRY; INTERLEUKIN-6; LIVER; MICE; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRICHOTHECENES; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

ANIMALIA;

EID: 70349292566     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfp150     Document Type: Article

References (62)

1. Ahmed, T. A., Buzzelli, M. D., Lang, C. H., Capen, J. B., Shumate, M. L., Navaratnarajah, M., Nagarajan, M., and Cooney, R. N. (2007). Interleukin-6 (IL-6) inhibits growth hormone (GH) mediated gene expression in hepatocytes. Am. J. Physiol Gastrointest. Liver Physiol. 292, G1793-G1803.
2. Alexander, W. S. (2002). Suppressors of cytokine signalling (SOCS) in the immune system. Nat. Rev. Immunol. 2, 410-416.
3. Amuzie, C. J., Harkema, J. R., and Pestka, J. J. (2008). Tissue distribution and proinflammatory cytokine induction by the trichothecene deoxynivalenol in the mouse: Comparison of nasal vs. oral exposure. Toxicology 248, 39-44.
4. Azcona-Olivera, J. I., Ouyang, Y. L., Warner, R. L., Linz, J. E., and Pestka, J. J. (1995). Effects of vomitoxin (deoxynivalenol) and cycloheximide on IL-2, 4, 5 and 6 secretion and mRNA levels in murine CD4+ cells. Food Chem. Toxicol. 33, 433-441.
5. Bae, H. K., and Pestka, J. J. (2008). Deoxynivalenol induces p38 interaction with the ribosome in monocytes and macrophages. Toxicol. Sci. 105, 59-66.
6. Bazan, J. F. (1989). A novel family of growth factor receptors: A common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain. Biochem. Biophys. Res. Commun. 164, 788-795.
7. Bergad, P. L., Schwarzenberg, S. J., Humbert, J. T., Morrison, M., Amarasinghe, S., Towle, H. C., and Berry, S. A. (2000). Inhibition of growth hormone action in models of inflammation. Am. J. Physiol. Cell Physiol. 279, C1906-C1917.
8. Boisclair, Y. R., Wang, J., Shi, J., Hurst, K. R., and Ooi, G. T. (2000). Role of the suppressor of cytokine signaling-3 in mediating the inhibitory effects of interleukin-1beta on the growth hormone-dependent transcription of the acid-labile subunit gene in liver cells. J. Biol. Chem. 275, 3841-3847.
9. Chen, Y., Sun, D., Krishnamurthy, V. M., and Rabkin, R. (2007). Endotoxin attenuates growth hormone induced hepatic insulin-like growth factor-1 expression by inhibiting JAK2/STAT5 signal transduction and STAT5b binding. Am. J. Physiol. Endocrinol. Metab. 292, E1856-E1862.
10. Chung, Y. J., Zhou, H. R., and Pestka, J. J. (2003). Transcriptional and posttranscriptional roles for p38 mitogen-activated protein kinase in upregulation of TNF-alpha expression by deoxynivalenol (vomitoxin). Toxicol. Appl. Pharmacol. 193, 188-201.
11. Creppy, E. E. (2002). Update of survey, regulation and toxic effects of mycotoxins in. Eur. Toxicol. Lett. 127, 19-28.
12. Croker, B. A., Kiu, H., and Nicholson, S. E. (2008). SOCS regulation of the JAK/STAT signalling pathway. Semin. Cell Dev. Biol. 19, 414-422.
13. De Benedetti, F., Alonzi, T., Moretta, A., Lazzaro, D., Costa, P., Poli, V., Martini, A., Ciliberto, G., and Fattori, E. (1997). Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J. Clin. Invest. 99, 643-650.
14. Denson, L. A., Held, M. A., Menon, R. K., Frank, S. J., Parlow, A. F., and Arnold, D. L. (2003). Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3. Am. J. Physiol. Gastrointest. Liver Physiol. 284, G646-G654.
15. Dong, W., Azcona-Olivera, J. I., Brooks, K. H., Linz, J. E., and Pestka, J. J. (1994). Elevated gene expression and production of interleukins 2, 4, 5, and 6 during exposure to vomitoxin (deoxynivalenol) and cycloheximide in the EL-4 thymoma. Toxicol. Appl. Pharmacol. 127, 282-290.
16. Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., et al. (1997). A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387, 921-924.
17. Fitzpatrick, D. W., Boyd, K. E., and Watts, B. M. (1988). Comparison of the trichothecenes deoxynivalenol and T-2 toxin for their effects on brain biogenic monoamines in the rat. Toxicol. Lett. 40, 241-245.
18. Forsell, J. H., Witt, M. F., Tai, J. H., Jensen, R., and Pestka, J. J. (1986). Effects of 8-week exposure of the B6C3F1 mouse to dietary deoxynivalenol (vomitoxin) and zearalenone. Food Chem. Toxicol. 24, 213-219.
19. Garcia, M. C., Wernstedt, I., Berndtsson, A., Enge, M., Bell, M., Hultgren, O., Horn, M., Ahren, B., Enerback, S., Ohlsson, C., et al. (2006). Mature-onset obesity in interleukin-1 receptor I knockout mice. Diabetes 55, 1205-1213.
20. Grove, J. F. (2007). The trichothecenes and their biosynthesis. Fortschr. Chem. Org. Naturst. 88, 63-130.
21. He, P., Young, L. G., and Forsberg, C. (1992). Microbial transformation of deoxynivalenol (vomitoxin). Appl. Environ. Microbiol. 58, 3857-3863.
22. Iverson, F., Armstrong, C., Nera, E., Truelove, J., Fernie, S., Scott, P., Stapley, R., Hayward, S., and Gunner, S. (1995). Chronic feeding study of deoxynivalenol in B6C3F1 male and female mice. Teratog. Carcinog. Mutagen. 15, 283-306.
23. Jungermann, K., and Kietzmann, T. (2000). Oxygen: Modulator of metabolic zonation and disease of the liver. Hepatology 31, 255-260.
24. Lang, C. H., Hong-Brown, L., and Frost, R. A. (2005). Cytokine inhibition of JAK-STAT signaling: A new mechanism of growth hormone resistance. Pediatr. Nephrol. 20, 306-312.
25. Lombaert, G. A., Pellaers, P., Roscoe, V., Mankotia, M., Neil, R., and Scott, P. M. (2003). Mycotoxins in infant cereal foods from the Canadian retail market. Food Addit. Contam. 20, 494-504.
26. Mao, Y., Ling, P. R., Fitzgibbons, T. P., McCowen, K. C., Frick, G. P., Bistrian, B. R., and Smith, R. J. (1999). Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo. Endocrinology 140, 5505-5515.
27. Matsumoto, A., Seki, Y., Kubo, M., Ohtsuka, S., Suzuki, A., Hayashi, I., Tsuji, K., Nakahata, T., Okabe, M., Yamada, S., et al. (1999). Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice. Mol. Cell Biol. 19, 6396-6407.
28. Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., et al. (1997). Structure and function of a new STAT-induced STAT inhibitor. Nature 387, 924-929.
29. O'Sullivan, L. A., Liongue, C., Lewis, R. S., Stephenson, S. E., and Ward, A. C. (2007). Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease. Mol. Immunol. 44, 2497-2506.
30. Obol'skii, O. L., Kravchenko, L. V., Avren'eva, L. I., and Tutel'ian, V. A. (1998). Effect of dietary selenium on the activity of UDP-glucuronosyl-transferases and metabolism of mycotoxin deoxynivalenol in rats. Vopr. Pitan. 4, 18-23.
31. Ogata, H., Chinen, T., Yoshida, T., Kinjyo, I., Takaesu, G., Shiraishi, H., Iida, M., Kobayashi, T., and Yoshimura, A. (2006). Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production. Oncogene 25, 2520-2530.
32. Pedersen, B. K., and Febbraio, M. A. (2008). Muscle as an endocrine organ: Focus on muscle-derived interleukin-6. Physiol. Rev. 88 1379-1406.
33. Pestka, J. J., and Amuzie, C. J. (2008). Tissue distribution and proinflammatory cytokine gene expression following acute oral exposure to deoxynivalenol: Comparison of weanling and adult mice. Food Chem. Toxicol. 46, 2826-2831.
34. Pestka, J. J., Lin, W. S., and Miller, E. R. (1987). Emetic activity of the trichothecene 15-acetyldeoxynivalenol in swine. Food Chem. Toxicol. 25, 855-858.
35. Pestka, J. J., and Smolinski, A. T. (2005). Deoxynivalenol: Toxicology and potential effects on humans. J. Toxicol. Environ. Health B Crit. Rev. 8, 39-69.
36. Pestka, J. J., and Zhou, H. R. (2002). Effects of tumor necrosis factor type 1 and 2 receptor deficiencies on anorexia, growth and IgA dysregulation in mice exposed to the trichothecene vomitoxin. Food Chem. Toxicol. 40, 1623-1631.
37. Prelusky, D. B. (1993). The effect of low-level deoxynivalenol on neurotransmitter levels measured in pig cerebral spinal fluid. J. Environ. Sci. Health B 28, 731-761.
38. Prelusky, D. B. (1994). The effect of deoxynivalenol on serotoninergic neurotransmitter levels in pig blood. J. Environ. Sci. Health B 29, 1203-1218.
39. Prelusky, D. B. (1997). Effect of intraperitoneal infusion of deoxynivalenol on feed consumption and weight gain in the pig. Nat. Toxins. 5, 121-125.
40. Prelusky, D. B., Hartin, K. E., Trenholm, H. L., and Miller, J. D. (1988). Pharmacokinetic fate of 14C-labeled deoxynivalenol in swine. Fundam. Appl. Toxicol. 10, 276-286.
41. Prelusky, D. B., Rotter, B. A., Thompson, B. K., and Trenholm, H. L. (1997). Effect of the appetite stimulant cyproheptadine on deoxynivalenol-induced reductions in feed consumption and weight gain in the mouse. J. Environ. Sci. Health B 32, 429-448.
42. Prelusky, D. B., and Trenholm, H. L. (1993). The efficacy of various classes of anti-emetics in preventing deoxynivalenol-induced vomiting in swine. Nat. Toxins. 1, 296-302.
43. Probert, L., Akassoglou, K., Alexopoulou, L., Douni, E., Haralambous, S., Hill, S., Kassiotis, G., Kontoyiannis, D., Pasparakis, M., Plows, D., et al. (1996). Dissection of the pathologies induced by transmembrane and wild-type tumor necrosis factor in transgenic mice. J. Leukoc. Biol. 59, 518-525.
44. Ram, P. A., and Waxman, D. J. (1999). SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J. Biol. Chem. 274, 35553-35561.
45. Rico-Bautista, E., Flores-Morales, A., and Fernandez-Perez, L. (2006). Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions. Cytokine Growth Factor Rev. 17, 431-439.
46. Rotter, B. A., Rotter, R. G., Thompson, B. K., and Trenholm, H. L. (1992). Investigations in the use of mice exposed to mycotoxins as a model for growing pigs. J. Toxicol. Environ. Health 37, 329-339.
47. Shumate, M. L., Yumet, G., Ahmed, T. A., and Cooney, R. N. (2005). Interleukin-1 inhibits the induction of insulin-like growth factor-I by growth hormone in CWSV-1 hepatocytes. Am. J. Physiol Gastrointest. Liver Physiol. 289, G227-G239.
48. Smolinski, A. T., and Pestka, J. J. (2005). Comparative effects of the herbal constituent parthenolide (Feverfew) on lipopolysaccharide-induced inflammatory gene expression in murine spleen and liver. J. Inflamm. (Lond). 2, 6.
49. Starr, R., Willson, T. A., Viney, E. M., Murray, L. J., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997). A family of cytokine-inducible inhibitors of signalling. Nature 387, 917-921.
50. Tan, J. C., and Rabkin, R. (2005). Suppressors of cytokine signaling in health and disease. Pediatr. Nephrol. 20, 567-575.
51. Thissen, J. P., and Verniers, J. (1997). Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture. Endocrinology 138, 1078-1084.
52. Tritscher, A. M., and Page, S. W. (2004). The risk assessment paradigm and its application for trichothecenes. Toxicol. Lett. 153, 155-163.
53. Trucksess, M. W., Thomas, F., Young, K., Stack, M. E., Fulgueras, W. J., and Page, S. W. (1995). Survey of deoxynivalenol in us 1993 wheat and barley crops by enzyme-linked-immunosorbent-assay. J. Aoac Int. 78, 631-636.
54. Wallenius, V., Wallenius, K., Ahren, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., and Jansson, J. O. (2002). Interleukin-6-deficient mice develop mature-onset obesity. Nat. Med. 8, 75-79.
55. Wolf, M., Bohm, S., Brand, M., and Kreymann, G. (1996). Proinflammatory cytokines interleukin 1 beta and tumor necrosis factor alpha inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells. Eur. J. Endocrinol. 135, 729-737.
56. Wong, S. S., Zhou, H. R., Marin-Martinez, M. L., Brooks, K., and Pestka, J. J. (1998). Modulation of IL-1beta, IL-6 and TNF-alpha secretion and mRNA expression by the trichothecene vomitoxin in the RAW 264.7 murine macrophage cell line. Food Chem. Toxicol. 36, 409-419.
57. Wormald, S., Zhang, J. G., Krebs, D. L., Mielke, L. A., Silver, J., Alexander, W. S., Speed, T. P., Nicola, N. A., and Hilton, D. J. (2006). The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling. J. Biol. Chem. 281, 11135-11143.
58. Yoshimura, A., Ohkubo, T., Kiguchi, T., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., Hara, T., and Miyajima, A. (1995). A Novel cytokine-inducible gene Cis encodes an Sh2-containing protein that binds to tyrosine-phosphorylated interleukin-3 and erythropoietin receptors. EMBO J. 14, 2816-2826.
59. Yumet, G., Shumate, M. L., Bryant, P., Lang, C. H., and Cooney, R. N. (2006). Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling. Crit. Care Med. 34, 1420-1427.
60. Zhou, H. R., Islam, Z., and Pestka, J. J. (2003). Rapid, sequential activation of mitogen-activated protein kinases and transcription factors precedes proinflammatory cytokine mRNA expression in spleens of mice exposed to the trichothecene vomitoxin. Toxicol. Sci. 72 130-142.
61. Zhou, H. R., Jia, Q., and Pestka, J. J. (2005). Ribotoxic stress response to the trichothecene deoxynivalenol in the macrophage involves the SRC family kinase Hck. Toxicol. Sci. 85, 916-926.
62. Zhou, H. R., Yan, D., and Pestka, J. J. (1997). Differential cytokine mRNA expression in mice after oral exposure to the trichothecene vomitoxin (deoxynivalenol): Dose response and time course. Toxicol. Appl. Pharmacol. 144, 294-305.